Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever - Alnylam
Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program - Alnylam
athenahealth to Host First Annual Investor Summit - Athenahealth
